Compound Detail
CHEMBL1355736
THEOPHYLLINE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
25
Targets
258
Activities
4
Assay Types
23
PK Parameters
20
Publications
30
Known Names
20
Indications
3
Mechanisms
Molecular Properties
180.2
MW (Da)
-1.04
ALogP
5
HBA
1
HBD
72.7
PSA (Ų)
0.56
QED
0
Ro5 Violations
0
Rot. Bonds
Drug Information
| Molecule Type | Protein |
| First Approval | 1976 |
| Availability | Prescription |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Phosphodiesterase 4 inhibitor | INHIBITOR | Phosphodiesterase 4 | ✓ | ✓ |
| Phosphodiesterase 3 inhibitor | INHIBITOR | Phosphodiesterase 3 | ✓ | ✓ |
| Adenosine receptor antagonist | ANTAGONIST | Adenosine receptor | ✓ | ✓ |
Indications
Asthma Bronchitis, Chronic Lung Diseases, Obstructive Pulmonary Disease, Chronic Obstructive Respiratory Insufficiency Altitude Sickness Apnea Hernias, Diaphragmatic, Congenital Kidney Diseases Leukemia Pseudohypoparathyroidism Pseudohypoparathyroidism Pseudohypoparathyroidism Renal Insufficiency, Chronic Severe Acute Respiratory Syndrome Virus Diseases Carcinoma, Non-Small-Cell Lung Depressive Disorder, Major Hypertension, Pulmonary Leukemia, Myeloid, Acute
ATC Classification
R03DA04
theophylline
Level 1: RESPIRATORY SYSTEM
Level 2: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03DA54
theophylline, combinations excl. psycholeptics
Level 1: RESPIRATORY SYSTEM
Level 2: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03DA74
theophylline, combinations with psycholeptics
Level 1: RESPIRATORY SYSTEM
Level 2: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Activity Summary
Ki 190 meas. best 9.22
IC50 55 meas. best 6.03
Kd 8 meas. best 6.4
EC50 5 meas. best 4.55
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Adenosine receptor A2a CHEMBL251 | Ki | 9.22 | 5.3808 | 0.6 | 24 |
| Adenosine receptor A1 CHEMBL226 | Ki | 9.22 | 5.3742 | 0.6 | 19 |
| Adenosine receptor A3 CHEMBL256 | Ki | 7.85 | 4.495 | 14.0 | 20 |
| Adenosine receptor CHEMBL2111386 | Ki | 6.82 | 5.38 | 150.0 | 6 |
| No relevant target CHEMBL2362975 | Kd | 6.4 | 6.4 | 400.0 | 1 |
| Adenosine receptor A1 CHEMBL318 | Ki | 6.16 | 4.9941 | 700.0 | 32 |
| Unchecked CHEMBL612545 | IC50 | 6.03 | 4.5375 | 940.0 | 4 |
| Adenosine A2 receptor CHEMBL2094117 | Ki | 5.88 | 4.7956 | 1310.0 | 18 |
| Adenosine receptor A2a CHEMBL251 | Kd | 5.79 | 5.5767 | 1642.3 | 3 |
| Adenosine receptor A1 CHEMBL4975 | IC50 | 5.61 | 5.255 | 2430.0 | 2 |
| Adenosine receptor A2b CHEMBL255 | Ki | 5.57 | 5.0914 | 2700.0 | 14 |
| Cavia porcellus CHEMBL369 | IC50 | 5.52 | 5.056 | 3000.0 | 5 |
| Adenosine receptor A1 CHEMBL4975 | Ki | 5.42 | 5.293 | 3800.0 | 10 |
| Adenosine receptor A2a CHEMBL302 | Ki | 5.17 | 4.7691 | 6700.0 | 11 |
| Adenosine receptor A1 CHEMBL2304404 | Ki | 5.01 | 4.7638 | 9800.0 | 8 |
| Trachea CHEMBL4296541 | IC50 | 4.94 | 4.94 | 11570.0 | 1 |
| Adenosine receptor A2a CHEMBL251 | IC50 | 4.92 | 4.92 | 12007.0 | 1 |
| Adenosine receptor A1 CHEMBL226 | Kd | 4.92 | 4.92 | 12000.0 | 1 |
| Adenosine receptor A2a CHEMBL2605 | Ki | 4.89 | 4.8425 | 13000.0 | 4 |
| Adenosine A2 receptor CHEMBL2094257 | Ki | 4.86 | 4.835 | 13800.0 | 4 |
| Adenosine receptor A2b CHEMBL2592 | Ki | 4.82 | 4.82 | 15100.0 | 3 |
| Adenosine receptor A1 CHEMBL226 | IC50 | 4.77 | 4.77 | 17104.0 | 1 |
| Adenosine receptor A1 CHEMBL318 | IC50 | 4.72 | 4.6567 | 19000.0 | 3 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 4.7 | 4.7 | 19900.0 | 1 |
| Unchecked CHEMBL612545 | Ki | 4.68 | 4.49 | 21000.0 | 3 |
| Cavia porcellus CHEMBL369 | EC50 | 4.55 | 4.55 | 28000.0 | 2 |
| Adenosine receptor A2a CHEMBL251 | EC50 | 4.55 | 4.55 | 28200.0 | 1 |
| Cavia porcellus CHEMBL369 | Kd | 4.53 | 4.53 | 29512.1 | 1 |
| Phosphodiesterase 4 CHEMBL2093863 | IC50 | 4.3 | 4.195 | 50000.0 | 2 |
| Phosphodiesterase 4 CHEMBL2093863 | Ki | 4.25 | 4.25 | 56800.0 | 2 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform CHEMBL3130 | IC50 | 4.12 | 4.12 | 75000.0 | 1 |
| Phosphodiesterase 3B CHEMBL5129 | Ki | 4.11 | 4.11 | 77000.0 | 1 |
| Alkaline phosphatase, tissue-nonspecific isozyme CHEMBL5979 | Ki | 4.09 | 4.09 | 82000.0 | 1 |
| Adenosine receptor A3 CHEMBL3360 | Ki | 4.07 | 4.035 | 85000.0 | 2 |
| Transmembrane domain-containing protein TMIGD3 CHEMBL3712907 | Ki | 4.06 | 4.06 | 86400.0 | 1 |
| Phosphodiesterase 3B CHEMBL5129 | IC50 | 4.05 | 4.05 | 90000.0 | 1 |
| Heart phosphodiesterase CHEMBL2111408 | IC50 | 4.04 | 4.04 | 92000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 2.2 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 1.5 | mL.min-1.kg-1 | Canis lupus familiaris |
| CL | 0.6 | mL.min-1.kg-1 | Homo sapiens |
| CL | 0.65 | mL.min-1.kg-1 | Homo sapiens |
| CL | 0.86 | mL.min-1.kg-1 | Homo sapiens |
| CL | 0.8 | mL.min-1.kg-1 | Homo sapiens |
| CL | 0.86 | mL.min-1.kg-1 | Homo sapiens |
| CL | 0.86 | mL.min-1.kg-1 | Homo sapiens |
| CL | 4.79 | mL.min-1.g-1 | Homo sapiens |
| CL | 5.75 | uL.min-1.(10^6cells)-1 | Rattus norvegicus |
| CL | 3.0 | uL.min-1.(10^6cells)-1 | Homo sapiens |
| CL | 2.6 | mL.min-1.kg-1 | Homo sapiens |
| CL | 1.73 | uL.min-1.(10^6cells)-1 | Homo sapiens |
| CL | 1.29 | mL.min-1.kg-1 | Homo sapiens |
| F | 80.0 | % | Homo sapiens |
| F | 98.8 | % | Homo sapiens |
| Fu | 0.46 | - | Homo sapiens |
| Fu | 0.61 | - | Homo sapiens |
| Fu | 0.61 | - | Homo sapiens |
| Fu | 0.53 | - | Not specified |
| Fu | 0.989 | - | Homo sapiens |
| MRT | 9.9 | hr | Homo sapiens |
| T1/2 | 7.2 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine